Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Castlevax Inc.

Clinical trials sponsored by Castlevax Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New nasal COVID vaccine could replace shots Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New nasal COVID vaccine could replace shots

Vaccine Ongoing

This Phase 2a trial tests a new nasal COVID-19 vaccine (NDV-HXP-S-KP.2) against an approved mRNA shot in 200 adults who have already been vaccinated. The goal is to see if the nasal vaccine is safe and tolerable. Participants are either 65 or older, or 18-64 with a condition that…

Phase 2 • Sponsor: CastleVax Inc. • Aim: Vaccine

Last updated Jul 24, 2026 00:00 UTC